Wilm's Tumor Clinical Trials Wilm's Tumor RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions:   Leukemia, Acute Myelogenous (AML);   Leukemia, Acute Lymphocytic (ALL);   Leukemia, Chronic Myelogenous (CML);   Myelodysplastic Syndrome (MDS);   Non-Hodgkin's Lymphoma (NHL)Interventions:   Drug: WT1 Peptide-Pulsed Dendritic Cells;   Drug: Donor Lymphocytes;   Drug: IL-4;   Drug: KLH;   Drug: WT1 Peptides;   Drug: EndotoxinSponsors:   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI)Completed - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 17, 2009 Category: Research Source Type: clinical trials